Overall, 105 children with URIs were divided into the three groups, with 35 in the honey group, 33 in the dextromethorphan group, and 37 in the no treatment group. There were no differences in symptom severity or duration of illness in the groups at baseline. All three groups showed significant symptom improvement (see accompanying table), with the honey group reporting the greatest improvement in all measured outcomes and the no treatment group experiencing the least improvement. Pairwise comparisons of the groups were performed, with no significant differences in outcomes observed between the honey and dextromethorphan groups, or the dextromethorphan and no treatment groups. However, honey significantly improved all outcomes compared with no treatment.